{"schema_version":"secwatch.filing_event.v1","accession":"0001393905-24-000114","form_type":"8-K","ticker":"STME","cik":"0001493712","company_name":"Stimcell Energetics Inc.","filed_at":"2024-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.648615+00:00","generated_at":"2026-06-04T02:17:09.097537+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Cell MedX elects four directors and increases authorized shares to 7.5B","bullets":["Elected directors: David Jeffs, George Adams, Joao (John) Da Costa, Amir Vahabzadeh effective April 1, 2024.","Authorized common stock increased from 300M to 7.5B shares ($0.001 par value).","Increase approved by written consent of stockholders holding 66% of outstanding shares.","No other material corporate changes were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001393905-24-000114","json":"https://secwatch.observer/filing/0001393905-24-000114.json","markdown":"https://secwatch.observer/filing/0001393905-24-000114.md","text":"https://secwatch.observer/filing/0001393905-24-000114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/0001393905-24-000114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/cmxc-20240401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:17:09.097537+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"35537024fe11fab4c5ac9eb9137bc72e39672233","claim":"Stimcell Energetics Inc.: Increase in authorized capital from 300,000,000 to 7,500,000,000 shares of common stock (effective 2024-04-01).","evidence_excerpt":"On April 1, 2024, Cell MedX Corp. (the “Company”), amended its articles of incorporation to increase the authorized capital of the Company from 300,000,000 shares of common stock, par value $0.001 (the “Common Stock”) to 7,500,000,000 shares of Common Stock (the “Increase in Authorized Capital”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/0001393905-24-000114-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-04-01"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}